Lameplast is the European leader in single-dose plastic packaging solutions in the pharmaceutical, ophthalmic and cosmetic industries. Flexible and integrated services for the design and manufacture of tailor-made containers, as well as automatic and semi-automatic filling and sealing machines for Lameplast’s and third parties’ single-dose packaging. US strategic presence through LF of America to favor a complete service in the Americas and support the success of overseas operations.
Opportunity to acquire Lameplast COC Group an Italian owned market leading business operating in a niche segment across pharmaceutical packaging and manufacturing. Attractive final market secured by high barriers to entry and the ability to grow via international business expansion and reinforcing management.
Separate Lameplast COC Group into two distinct businesses, Lameplast and COC Farmaceutici
Sourced and hired CEO and CFO with long-standing international experience
Develop US operations through strategic partnership with a local player, whilst maintaining R&D and IP in-house
Significantly enhanced R&D activity to create a consistent pipeline of new products
Introduced accurate and timely reporting schemes to monitor and optimise operational efficiency and financial performance